Gulfaraz Khan

39.8k total citations
81 papers, 3.8k citations indexed

About

Gulfaraz Khan is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Gulfaraz Khan has authored 81 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 28 papers in Epidemiology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Gulfaraz Khan's work include Viral-associated cancers and disorders (36 papers), Lymphoma Diagnosis and Treatment (18 papers) and Parvovirus B19 Infection Studies (13 papers). Gulfaraz Khan is often cited by papers focused on Viral-associated cancers and disorders (36 papers), Lymphoma Diagnosis and Treatment (18 papers) and Parvovirus B19 Infection Studies (13 papers). Gulfaraz Khan collaborates with scholars based in United Arab Emirates, United Kingdom and United States. Gulfaraz Khan's co-authors include Muhammad Jawad Hashim, Philip J. Coates, H. O. Kangro, G Slavin, Ruth F. Jarrett, Éric Cabannes, Fabienne Aillet, Ronald T. Hay, R. B. Heath and Pierre Dubus and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and PLoS ONE.

In The Last Decade

Gulfaraz Khan

80 papers receiving 3.7k citations

Peers

Countries citing papers authored by Gulfaraz Khan

Since Specialization

Citations

This map shows the geographic impact of Gulfaraz Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gulfaraz Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gulfaraz Khan more than expected).

Fields of papers citing papers by Gulfaraz Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gulfaraz Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gulfaraz Khan. The network helps show where Gulfaraz Khan may publish in the future.

Co-authorship network of co-authors of Gulfaraz Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Gulfaraz Khan. A scholar is included among the top collaborators of Gulfaraz Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gulfaraz Khan. Gulfaraz Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hidden in Plain Sight: The Diagnostic Quest of Zeive Syndrome 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Huyen Q. Pham, Gulfaraz Khan, Ali Mahmoud, (unknown)	0
2	Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections 2025 ·Journal of Epidemiology and Global Health ·Gulfaraz Khan, Muhammad Jawad Hashim	14
3	Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis 2024 ·Frontiers in Immunology ·(unknown), Gulfaraz Khan	5
4	Monkeypox: Past, Present, and Future 2024 ·Advances in experimental medicine and biology ·Gulfaraz Khan, Nighat Perveen	6
5	Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model 2023 ·Vaccines ·(unknown), (unknown), (unknown), Dagmar Pich, Wolfgang Hammerschmidt, Gulfaraz Khan	4
6	Effectiveness of containment strategies in preventing SARS-CoV-2 transmission 2022 ·Journal of Infection and Public Health ·(unknown), Qianbing Zhang, Muhammad Jawad Hashim, (unknown), (unknown), (unknown), Xiang Li, Yanhui Liu, Haohui Deng, (unknown), (unknown), (unknown), Yu Zhang, (unknown), (unknown), (unknown), Shui Shan Lee, Ziad A. Memish, Guozhi Jiang, Gulfaraz Khan	8
7	Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis 2021 ·Frontiers in Immunology ·(unknown), (unknown), Safa Shehab, Gulfaraz Khan	9
8	A simulated measurement for COVID-19 pandemic using the effective reproductive number on an empirical portion of population: epidemiological models 2021 ·Neural Computing and Applications ·Belal Alsinglawi, Omar Mubin, Fady Alnajjar, Khalid Kheirallah, Mahmoud Elkhodr, Mohammed Al-Zobbi, (unknown), Mudassar Hassan Arsalan, Tahmina Nasrin Poly, Munkhjargal Gochoo, Gulfaraz Khan, Kapal Dev	1
9	Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017 2020 ·BMJ Open ·Gulfaraz Khan, Christina Fitzmaurice, Mohsen Naghavi, Luai A. Ahmed	76
10	Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells 2018 ·PLoS ONE ·(unknown), John R. Corboy, Suhail Al‐Salam, Gulfaraz Khan	108
11	Epstein-Barr Virus-Encoded Small RNAs (EBERs) Are Present in Fractions Related to Exosomes Released by EBV-Transformed Cells 2014 ·PLoS ONE ·(unknown), (unknown), Saeed Tariq, Gulfaraz Khan	75
12	Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells 2011 ·Experimental and Molecular Pathology ·Gulfaraz Khan, (unknown), (unknown), (unknown), Sayel Daoud	24
13	Pandemic (H1N1) 2009, Abu Dhabi, United Arab Emirates, May 2009–March 2010 2011 ·Emerging infectious diseases ·Gulfaraz Khan, (unknown), Muhammad Jawad Hashim	4
14	Phenotype and frequency of Epstein–Barr virus‐infected cells in pretreatment blood samples from patients with Hodgkin lymphoma 2005 ·British Journal of Haematology ·Gulfaraz Khan, Annette Lake, Lesley Shield, June Freeland, (unknown), Freda E. Alexander, Robert M. Jackson, Penelope R. A. Taylor, (unknown), Ruth F. Jarrett	17
15	Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα 1999 ·Oncogene ·Éric Cabannes, Gulfaraz Khan, Fabienne Aillet, Ruth F. Jarrett, Ronald T. Hay	267
16	Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data 1997 ·International Journal of Cancer ·Sally L. Glaser, (unknown), Susan L. Stewart, Richard F. Ambinder, Ruth F. Jarrett, Pierre Brousset, Gorm Pallesen, Margaret L. Gulley, Gulfaraz Khan, Jane O'Grady, Michael Hummel, María Victoria Preciado, Hans Knecht, John K. C. Chan, Alexander Claviez	367
17	Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data 1997 ·International Journal of Cancer ·Sally L. Glaser, (unknown), (unknown), Richard F. Ambinder, Ruth F. Jarrett, Pierre Brousset, Gorm Pallesen, Margaret L. Gulley, Gulfaraz Khan, Jane O'Grady, Michael Hummel, María Victoria Preciado, Hans Knecht, John K. C. Chan, Alexander Claviez	33
18	DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. 1997 ·Gut ·Henry Debinski, Michael A. Kamm, I C Talbot, Gulfaraz Khan, H. O. Kangro, David Jeffries	73
19	The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. 1996 ·The Journal of Experimental Medicine ·L L Decker, (unknown), Gulfaraz Khan, Richard B. Freeman, Bruce J. Dezube, Phil Lieberman, David A. Thorley‐Lawson	214
20	The role of Epstein‐Barr virus in the pathogenesis of Hodgkin's disease 1994 ·The Journal of Pathology ·Gulfaraz Khan, Philip J. Coates	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact